ALTIMMUNE, INC. Other Comprehensive Income (Loss), Net of Tax
ALTIMMUNE, INC. (ALT) reported Other Comprehensive Income (Loss), Net of Tax of -$9.97 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-11.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2015-03-11
- ALTIMMUNE, INC. other comprehensive income (loss), net of tax for the quarter ending 2014-12-31 was -$2.63M.
- ALTIMMUNE, INC. other comprehensive income (loss), net of tax for the quarter ending 2014-09-30 was -$4.63M.
- ALTIMMUNE, INC. other comprehensive income (loss), net of tax for the quarter ending 2014-06-30 was -$439.76K.
- ALTIMMUNE, INC. other comprehensive income (loss), net of tax for the quarter ending 2014-03-31 was -$2.26M.
- ALTIMMUNE, INC. other comprehensive income (loss), net of tax for fiscal 2014 was -$9.97M.
- ALTIMMUNE, INC. other comprehensive income (loss), net of tax for fiscal 2013 was -$11.72M.
- ALTIMMUNE, INC. other comprehensive income (loss), net of tax for fiscal 2012 was -$6.15M.
- ALTIMMUNE, INC. other comprehensive income (loss), net of tax for fiscal 2011 was -$4.04M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2014-12-31 | -$2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | -$7.27M derived: sum of 2 quarters · filed 2015-03-11 | -$7.71M derived: sum of 3 quarters · filed 2015-03-11 | -$9.97M 10-K · filed 2015-03-11 |
| 2014-09-30 | -$4.63M 10-Q · filed 2014-11-06 | -$5.07M derived: sum of 2 quarters · filed 2014-11-06 | -$7.33M 10-Q · filed 2014-11-06 | -$11.76M derived: sum of 4 quarters · filed 2015-03-11 |
| 2014-06-30 | -$439.76K 10-Q · filed 2014-08-05 | -$2.70M 10-Q · filed 2014-08-05 | -$7.12M derived: sum of 3 quarters · filed 2015-03-11 | -$11.07M derived: sum of 4 quarters · filed 2015-03-11 |
| 2014-03-31 | -$2.26M 10-Q · filed 2014-05-08 | -$6.68M derived: sum of 2 quarters · filed 2015-03-11 | -$10.63M derived: sum of 3 quarters · filed 2015-03-11 | -$11.87M derived: sum of 4 quarters · filed 2015-03-11 |
| 2013-12-31 | -$4.42M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | -$8.37M derived: sum of 2 quarters · filed 2015-03-11 | -$9.61M derived: sum of 3 quarters · filed 2015-03-11 | -$11.72M 10-K · filed 2015-03-11 |
| 2013-09-30 | -$3.95M 10-Q · filed 2014-11-06 | -$5.18M derived: sum of 2 quarters · filed 2014-11-06 | -$7.30M 10-Q · filed 2014-11-06 | -$8.57M derived: sum of 4 quarters · filed 2015-03-11 |
| 2013-06-30 | -$1.24M 10-Q · filed 2014-08-05 | -$3.35M 10-Q · filed 2014-08-05 | -$4.62M derived: sum of 3 quarters · filed 2015-03-11 | -$6.06M derived: sum of 4 quarters · filed 2015-03-11 |
| 2013-03-31 | -$2.11M 10-Q · filed 2014-05-08 | -$3.38M derived: sum of 2 quarters · filed 2015-03-11 | -$4.82M derived: sum of 3 quarters · filed 2015-03-11 | -$5.59M derived: sum of 4 quarters · filed 2015-03-11 |
| 2012-12-31 | -$1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | -$2.71M derived: sum of 2 quarters · filed 2015-03-11 | -$3.48M derived: sum of 3 quarters · filed 2015-03-11 | -$6.15M 10-K · filed 2015-03-11 |
| 2012-09-30 | -$1.43M 10-Q · filed 2013-11-07 | -$2.21M derived: sum of 2 quarters · filed 2013-11-07 | -$4.88M 10-Q · filed 2013-11-07 | |
| 2012-06-30 | -$776.45K 10-Q · filed 2013-08-08 | -$3.44M 10-Q · filed 2013-08-08 | ||
| 2012-03-31 | -$2.67M 10-Q · filed 2013-05-08 | |||
| 2011-12-31 | -$4.04M 10-K · filed 2014-03-11 | |||
| 2010-12-31 | -$34.79M 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |